Contract facts
NONENo full NAICS 325412 intel page yet. Browse NAICS intelligence
TOTAL PARENTERAL NUTRITION, AMINO ACIDS, FAT EMULSION, AND CARIOPLEGIA ADMIXTURES PROVIDED BY CENTRAL ADMIXTURE PHARMACY SERVICES (CAPS) FOR THE WRNMMC PHARMACY. is a federal NONE award for Defense Health Agency held by Central Admixture Pharmacy Services, Inc. Estimated value $200K ($200K obligated). Current period of performance ends Jun 29, 2026. Last award drew 1 bidder. Place of performance: BETHESDA MD.
TOTAL PARENTERAL NUTRITION, AMINO ACIDS, FAT EMULSION, AND CARIOPLEGIA ADMIXTURES PROVIDED BY CENTRAL ADMIXTURE PHARMACY SERVICES (CAPS) FOR THE WRNMMC PHARMACY.
Recompete timing
PublicCurrent PoP ended Jun 29, 2026 (53 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordCentral Admixture Pharmacy Services, Inc — $5.4M obligated across 70 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001425F0045?
HT001425F0045 (CAPS and services) is a Defense Health Agency award with a potential value of $200K, currently held by Central Admixture Pharmacy Services, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0014-25-F-0045?
HT0014-25-F-0045 is the dashed form of PIID HT001425F0045 (CAPS and services), held by Central Admixture Pharmacy Services, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT001425F0045?
Defense Health Agency awarded HT001425F0045 to Central Admixture Pharmacy Services, Inc (potential $200K).
Who is the incumbent on HT001425F0045?
Central Admixture Pharmacy Services, Inc is the incumbent with $5.4M across 70 related awards in SCOUT’s public footprint. The current period of performance ends Jun 29, 2026.
When does Central Admixture Pharmacy Services, Inc’s HT001425F0045 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.